Bath & Body Works (NYSE:BBWI) Earns “Outperform” Rating from Telsey Advisory Group

Telsey Advisory Group reiterated their outperform rating on shares of Bath & Body Works (NYSE:BBWI) in a research note published on Thursday, Benzinga reports. The firm currently has a $42.00 target price on the stock.

Several other analysts also recently issued reports on the company. Morgan Stanley cut their price target on Bath & Body Works from $56.00 to $51.00 and set an overweight rating on the stock in a report on Thursday, September 5th. The Goldman Sachs Group cut their price objective on shares of Bath & Body Works from $60.00 to $49.00 and set a buy rating on the stock in a research report on Thursday, August 29th. BMO Capital Markets restated an outperform rating and issued a $50.00 target price (down previously from $52.00) on shares of Bath & Body Works in a research report on Thursday, August 29th. Bank of America cut their price target on Bath & Body Works from $54.00 to $45.00 and set a buy rating on the stock in a report on Thursday, August 29th. Finally, Evercore ISI decreased their price objective on Bath & Body Works from $45.00 to $35.00 and set an in-line rating for the company in a report on Wednesday, August 28th. Eight analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of Moderate Buy and an average price target of $42.35.

Bath & Body Works Trading Up 2.0 %

Shares of NYSE BBWI opened at $32.39 on Thursday. The company has a market capitalization of $7.10 billion, a price-to-earnings ratio of 8.35, a price-to-earnings-growth ratio of 0.96 and a beta of 1.77. Bath & Body Works has a twelve month low of $26.20 and a twelve month high of $52.99. The business has a 50 day simple moving average of $31.85 and a 200-day simple moving average of $40.27.

Bath & Body Works (NYSE:BBWI) last released its earnings results on Wednesday, August 28th. The company reported $0.37 earnings per share for the quarter, beating the consensus estimate of $0.35 by $0.02. Bath & Body Works had a net margin of 12.69% and a negative return on equity of 41.94%. The firm had revenue of $1.53 billion during the quarter, compared to analyst estimates of $1.54 billion. As a group, equities analysts predict that Bath & Body Works will post 3.18 earnings per share for the current year.

Bath & Body Works Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, September 6th. Shareholders of record on Friday, August 23rd were paid a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a yield of 2.47%. The ex-dividend date was Friday, August 23rd. Bath & Body Works’s dividend payout ratio (DPR) is currently 20.62%.

Institutional Trading of Bath & Body Works

Several hedge funds and other institutional investors have recently modified their holdings of BBWI. Anomaly Capital Management LP purchased a new stake in Bath & Body Works in the 2nd quarter worth about $113,995,000. Lone Pine Capital LLC boosted its holdings in shares of Bath & Body Works by 20.0% during the fourth quarter. Lone Pine Capital LLC now owns 10,448,872 shares of the company’s stock worth $450,973,000 after purchasing an additional 1,742,471 shares during the period. Cadian Capital Management LP purchased a new position in Bath & Body Works during the fourth quarter valued at approximately $58,266,000. Vanguard Group Inc. increased its stake in Bath & Body Works by 4.2% in the 1st quarter. Vanguard Group Inc. now owns 27,398,192 shares of the company’s stock valued at $1,370,458,000 after buying an additional 1,102,124 shares during the period. Finally, KBC Group NV lifted its position in Bath & Body Works by 5,406.5% in the 4th quarter. KBC Group NV now owns 1,118,706 shares of the company’s stock worth $48,284,000 after buying an additional 1,098,390 shares in the last quarter. Institutional investors and hedge funds own 95.14% of the company’s stock.

Bath & Body Works Company Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.